Synopsis

Source of validity: Scientific
Rating (out of 5): 3

Resveratrol, a polyphenolic compound found in grapes, berries, and peanuts, has garnered scientific interest for its potential role in managing metabolic syndrome. Metabolic syndrome is a cluster of conditions including insulin resistance, hypertension, dyslipidemia, and central obesity, all of which increase the risk of cardiovascular disease and type 2 diabetes. Preclinical studies and a growing number of human clinical trials suggest that resveratrol and its metabolites (including various conjugates formed after ingestion) may support metabolic health through several mechanisms. These include improving insulin sensitivity, reducing inflammation, modulating lipid metabolism, and acting as antioxidants. For example, systematic reviews and meta-analyses of randomized controlled trials (RCTs) have reported modest improvements in fasting glucose, insulin sensitivity, and blood pressure with resveratrol supplementation, though results are somewhat inconsistent and often dose-dependent.

However, most clinical evidence utilizes purified resveratrol rather than specific conjugates or "mixed" forms, and the bioavailability of resveratrol is low, with much of it rapidly converted to glucuronide and sulfate conjugates in the body. Some research suggests these metabolites may also exhibit biological activity, but their individual effects are less well characterized. Overall, while the scientific rationale for resveratrol’s use in metabolic syndrome is supported by biochemical and clinical data, the evidence is moderate (rating 3), and further well-powered studies are needed to clarify the efficacy and optimal formulation, specifically concerning mixed or conjugated forms.

More about Resveratrol conjugates (mixed)
More about Metabolic Syndrome

Other ingredients used for Metabolic Syndrome

Other health conditions supported by Resveratrol conjugates (mixed)

Products containing Resveratrol conjugates (mixed)